Effects of a multicomponent training followed by a detraining period on metabolic syndrome profile of older adults

Exp Gerontol. 2024 Feb:186:112363. doi: 10.1016/j.exger.2024.112363. Epub 2024 Jan 19.

Abstract

Aims: The present study sought to analyze the effects of 6-month multicomponent training (MCT) combined with a 4-month detraining on metabolic syndrome (MetS) profile among older adults with decreased functional capacity.

Methods: This quasi-experimental study included a total of 104 older adults (80.5 ± 6.0 years) and the sample was divided into a training (TRAIN, n = 55) or control group (CON). Harmonized definition was used to diagnose the MetS. Functional capacity, blood biochemical parameters, blood pressure, body composition and anthropometric measurements were assessed 3 times. Analysis of variance for repeated measures and Wilcoxon signed-rank test were used to check the differences within groups.

Results: TRAIN decreased diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDLC) and total fat mass during training period, whereas CON did not show any significant changes. During detraining, TRAIN increased HDLC, systolic blood pressure (SBP), waist circumference (WC) and total fat mass; and decreased glucose and fat free mass, whereas CON increased the concentration of glucose and HDLC. From baseline to post-detraining assessment, CON increased the concentration of triglycerides and the WC, while TRAIN only increased the WC (all p < 0.05).

Conclusions: Exercise can be a key component in the treatment of the MetS, since MCT seems to be effective to decrease DBP and total fat mass. Nevertheless, 4-months of detraining could cause a drop of total fat mass, but no in DBP. To avoid reversibility of the benefits obtained, it could be beneficial to promote continuing exercise programs.

Trial registration: ClinicalTrial.gov identifier: NCT03831841.

Keywords: Cardiovascular diseases; Diabetes; Exercise; Healthy aging; Obesity.

MeSH terms

  • Aged
  • Blood Pressure
  • Cholesterol, HDL
  • Exercise / physiology
  • Glucose
  • Humans
  • Metabolic Syndrome* / therapy
  • Triglycerides

Substances

  • Triglycerides
  • Cholesterol, HDL
  • Glucose

Associated data

  • ClinicalTrials.gov/NCT03831841